Indaptus Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -2,541 | -8,112 | -2,975 | -5,228 |
Net Income | -2,541 | -8,112 | -2,975 | -5,228 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -7,009 | -3,190 | -3,054 | -4,018 |
Cash | 1,497 | 8,507 | 5,825 | 6,157 |
Basic Shares | 2,167 | 2,167 | 5,761 | 5,761 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -1 | -1 | ||
EBITDA | -20,848 | -15,021 | -15,422 | -14,321 |
EBIT | -15,022 | -15,423 | -14,322 | |
Net Income | -20,848 | -15,022 | -15,423 | -14,322 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -14,823 | -12,323 | -13,405 | -13,250 |
Cash | 8,507 | 5,786 | 13,362 | 9,626 |
Basic Shares | 966 | 9,355 | 8,401 | 8,262 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$9.19 |
2025-09-30 | -$2.98 |
2025-06-30 | -$9.09 |
2025-03-31 | -$9 |